Honz Pharmaceutical Co., Ltd. (SZSE: 300086)
Health Care · Pharmaceuticals · CN
CN¥5.49
+2.23% today · -22.3% 1Y
Honz Pharmaceutical Co., Ltd. (SZSE: 300086) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $373.04M and employs 540 people.
Over the last twelve months the share price has lost 22.3%, trading between 5.22 and 15.19.
Tweenvest scores Honz Pharmaceutical Co., Ltd. across four factors: quality 48/100, value 33/100, growth 24/100. Its strongest factor is quality.
300086 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $373.04M
- Revenue (TTM)
- $55.73M
- P/E
- —
- EPS
- -0.46
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- CN¥15.19
- 52-week low
- CN¥5.22
- Avg volume (3M)
- —
- Shares outstanding
- 455.12M
- Employees
- 540
- Next earnings
- —
About Honz Pharmaceutical Co., Ltd.
Honz Pharmaceutical Co., Ltd. is a Chinese enterprise based in Guangzhou, primarily engaged in the creation, production, and commercialization of pharmaceutical drugs. While specializing in pediatric medications, the company also provides treatments for adults across a broad spectrum of health concerns. Its product offerings address conditions such as allergic responses, digestive and diarrheal issues, respiratory problems like coughs and flu, fevers, various infections, fungal ailments, pain relief, and endocrine disorders. Honz Pharmaceutical distributes its products to the market via an extensive network of agents and numerous retail sales outlets. The company officially adopted its current name in November 2016, having previously operated as HaiNan Honz Pharmaceutical Co.,Ltd.
- ISIN
- CNE100000QM6
- Founded
- 1993
- Listed since
- May 26, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KYORIN Pharmaceutical Co., Ltd.TSE: 4569 | $382.76M | ¥1,055.00 | -0.94% |
| Kwality Pharmaceuticals LimitedBSE: 539997 | $381.97M | Rs3,562.70 | -0.27% |
| Verano Holdings Corp.CNSX: VRNO | $381.78M | CA$7.44 | -0.67% |
| Shinpoong Pharmaceutical Co.,LtdKOSE: A019170 | $375.67M | ₩9,780.00 | +5.73% |
| Zhejiang Shengda Bio-Pharm Co., Ltd.SHSE: 603079 | $372.46M | CN¥13.31 | -2.20% |
| Taho Pharmaceuticals Ltd.TPEX: 6467 | $368.78M | NT$225.00 | -2.60% |
| Egyptian International Pharmaceutical Industries CompanyCASE: PHAR | $367.68M | EGP114.10 | -1.47% |
| GlaxoSmithKline Pakistan LimitedKASE: GLAXO | $364.11M | PKRs316.60 | +1.20% |
Figures last refreshed Oct 11, 2026.